HFpEF and 2-year Mortality of COPD Patients

University Hospital Olomouc150 enrolled

Overview

This study was designed to assess potential relationship between heart failure with preserved ejection fraction and 2- year mortality of patients with chronic obstructive pulmonary disease

Study Type

OBSERVATIONAL

Enrollment

150

Conditions

Chronic Obstructive Pulmonary Disease Heart Failure

Interventions

Cardiac function assessmentDIAGNOSTIC_TEST

Echocardiography, cardiac enzymes analysis

Eligibility

Sex: ALLMin age: 40 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: Exacerbation of chronic obstructive pulmonary disease requiring hospitalization Age 40 - 80 years Performance status 0-1 according to Eastern Cooperative Oncology Group (ECOG) Long acting beta agonist (LABA)/ long acting antimuscarinic (LAMA) bronchodilator treatment Exclusion Criteria: Presence of major heart valve dysfunction Documented noncompliance with treatment Presence of active malignancy Body mass index \> 40 Interstitial lung disease

Locations (2)

Frydek Mistek Hospital

Frýdek-Místek, Czechia

NOT_YET_RECRUITING

University Hospital Olomou

Olomouc, Czechia

RECRUITING

Outcomes

Primary Outcomes

Mortality

Mortality of patients

Time frame: 2 year

Central Contacts

Milan Sova, Ph.D.

CONTACT

588445326 milan.sova@email.cz

Ondrej Zela, MD

CONTACT

ondrej.zela@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.